Diabetes among the Métis of Canada: Defining the Population, Estimating the Disease

Canadian Journal of Diabetes

Volumn 27, Issue 4, 2003, Pages 442-448

  Bruce, Sharon G ^a   Kliewer, Erich V ^a,b,c   Young, T Kue ^d   Mayer, Teresa ^b   Wajda, Andre ^b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CancerCare Manitoba ^*  (Canada)

^c Epidemiology Unit   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ABORIGINE; ADOLESCENT; ADULT; AGED; CANADA; COMORBIDITY; DIABETES MELLITUS; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; REVIEW;

EID: 0347763867     PISSN: 14992671     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Young TK, Reading J, Elias B, et al. Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress. CMAJ. 2000;163:561-566.
2. Métis National Council. The Métis Nation on the Move. Report on the Métis Nation's Constitutional Parallel Process. Ottawa, ON: Métis National Council; 1992.
3. Miller JR. Skyscrapers Hide the Heavens: A History of Indian-White Relations in Canada. Rev ed. Toronto, ON: University of Toronto Press; 1991.
4. Foster JE. The Métis: the people and the term. Prairie Forum. 1978;3:79-90.
5. Peterson J, Brown JSH. Introduction. In: Peterson J, Brown JSH, eds. The New Peoples: Being and Becoming Métis in North America. Winnipeg, MB: University of Manitoba Press; 1985:3-16.
6. Royal Commission on Aboriginal Peoples. Report of the Royal Commission on Aboriginal Peoples. Perspectives and Realities. Vol 4. Ottawa, ON: Minister of Supply and Services; 1996.
7. Métis National Council. Available at: http://www.metis nation.ca. Accessed September 18, 2003.
8. Normand J. A Profile of the Métis. Ottawa, ON: Statistics Canada; 1996.
9. Statistics Canada. The Aboriginal Peoples Survey. Microdata File-Adult User's Guide. Ottawa, ON: Statistics Canada; 1995.
10. Blanchard JF, Ludwig S, Wajda A, et al. Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care. 1996;19:807-811.
11. Kliewer E, Mayer T, Wajda A. The Health of Manitoba's Métis Population and Their Utilization of Medical Services: A Pilot Study. Winnipeg, MB: CancerCare Manitoba and Manitoba Health; 2002.
12. Roos LL, Mustard CA, Nicol JP, et al. Registries and administrative data: organization and accuracy. Med Care. 1993; 31:201-212.
13. Kraut A, Walld R, Tate R, et al. Impact of diabetes on employment and income in Manitoba, Canada. Diabetes Care. 2001;24:64-68.
14. Statistics Canada. Health Status of Canadians: Report of the 1991 General Social Survey. Ottawa, ON: Statistics Canada; 1994.
15. Bruce S. Prevalence and determinants of diabetes mellitus among the Métis of western Canada. Am J Human Biol. 2000;12:542-551.
16. Bruce SG. The impact of diabetes mellitus among the Métis of western Canada. Ethn Health. 2000;5:47-57.
17. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes. 1987;36:523-534.
18. Young TK, Mustard CA. Undiagnosed diabetes: does it matter? CMAJ. 2001;164:24-28.
19. Blanchard JF, Wajda A, Green C. Epidemiologic Projections of Diabetes and its Complications: Forecasting the Coming Storm. Winnipeg, MB: Manitoba Health; 1998.
20. Songer TJ. Disability in diabetes. In: Diabetes in America. 2nd ed. Bethesda, MD: National Diabetes Data Group, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:259-282.
21. Roos LL, Roman PS, Ferguson P. Administrative databases. In: Armitage P, Cotton T, eds. Encyclopedia of Biostatistics. Vol 1. Chichester, UK: John Wiley; 1998:62-73.
22. Robinson JR, Young TK, Roos LL, et al. Estimating the burden of disease. Comparing administrative data and self-reports. Med Care. 1997;35:932-947.
23. Roos NP, Shapiro E. Revisiting the Manitoba Centre for Health Policy and Evaluation and its population-based health information system. Med Care. 1999;37(suppl 6):JS10-JS14.
24. Meltzer S, Leiter L, Daneman D, et al. 1998 clinical practice guidelines for the management of diabetes in Canada. CMAJ. 1998;159(suppl 8):S1-S29.
25. American Diabetes Association and National Institute of Diabetes, Digestive and Kidney Diseases. The prevention of delay of type 2 diabetes. Diabetes Care. 2002;25:742-749.
26. Guillausseau PJ, Massin P, Charles MA, et al. Glycaemic control and development of retinopathy in type 2 diabetes mellitus: a longitudinal study. Diabet Med. 1998;15:151-155.
27. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
28. Coutinho M, Gerstein HC, Wang Y, et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999; 22:233-240.
29. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998; 352:837-853.
30. Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355:253-259.
31. Roman SH, Harris MI. Management of diabetes mellitus from a public health perspective. Endocrinol Metab Clin North Am. 1997;26:443-474.